(Amendment No. 4)*
1.
|
NAME OF REPORTING PERSONS
|
|
|
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
|
|
|
|
|
|
DRACO Capital Investment Management Company S.A.
|
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
|
|
(a)
|
[X]
|
|
|
(b)
|
[ ]
|
5.
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
|
[_]
|
|
|
|
|
|
|
6.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
|
|
Uruguay
|
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
|
|
|
8.
|
SHARED VOTING POWER
|
|
|
|
|
|
7,991,226
|
|
9.
|
SOLE DISPOSITIVE POWER
|
|
|
|
|
0
|
|
10.
|
SHARED DISPOSITIVE POWER
|
|
[_]
|
|
|
|
|
7,991,226
|
|
11.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
|
|
|
PERSON
|
|
|
7,991,226
|
|
12.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
|
|
|
CERTAIN SHARES*
|
|
|
|
|
13.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
|
|
|
19.4%
|
|
14.
|
TYPE OF REPORTING PERSON*
|
|
|
|
|
|
OO, IA
|
|
1.
|
NAME OF REPORTING PERSONS
|
|
|
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
|
|
|
|
|
|
5D+ Draco I Latam Income Plus Segregated Portfolio
|
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
|
|
(a)
|
[X]
|
|
|
(b)
|
[ ]
|
5.
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
|
[_]
|
|
|
|
|
|
|
6.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
|
|
Cayman Islands
|
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
|
|
|
8.
|
SHARED VOTING POWER
|
|
|
|
|
|
7,991,226
|
|
9.
|
SOLE DISPOSITIVE POWER
|
|
|
|
|
0
|
|
10.
|
SHARED DISPOSITIVE POWER
|
|
[_]
|
|
|
|
|
7,991,226
|
|
11.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
|
|
|
PERSON
|
|
|
7,991,226
|
|
12.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
|
|
|
CERTAIN SHARES*
|
|
|
|
|
13.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
|
|
|
19.4%
|
|
14.
|
TYPE OF REPORTING PERSON*
|
|
|
|
|
|
CO
|
|
1.
|
NAME OF REPORTING PERSONS
|
|
|
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
|
|
|
|
|
|
Biotech Investment Holding Ltd.
|
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
|
|
(a)
|
[X]
|
|
|
(b)
|
[ ]
|
5.
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
|
[_]
|
|
|
|
|
|
|
6.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
|
|
British Virgin Islands
|
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
|
|
|
8.
|
SHARED VOTING POWER
|
|
|
|
|
|
7,991,226
|
|
9.
|
SOLE DISPOSITIVE POWER
|
|
|
|
|
0
|
|
10.
|
SHARED DISPOSITIVE POWER
|
|
[_]
|
|
|
|
|
7,991,226
|
|
11.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
|
|
|
PERSON
|
|
|
7,991,226
|
|
12.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
|
|
|
CERTAIN SHARES*
|
|
|
|
|
13.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
|
|
|
19.4%
|
|
14.
|
TYPE OF REPORTING PERSON*
|
|
|
|
|
|
CO
|
|
Item 1.
|
Security and Issuer.
|
|
The name of the issuer is Bioceres Crop Solutions Corp. (the "Issuer"). The address of the Issuer's principal executive offices is Ocampo 210 bis Predio CCT, Rosario, Santa Fe, Argentina. This Schedule 13D relates to the Issuer's Ordinary Shares, par value US$0.0001 per share (the "Shares").
|
Item 2.
|
Identity and Background.
|
|
(a-c, f) This Schedule 13D is being filed jointly
by DRACO Capital Investment Management Company S.A., a company incorporated under the laws of Uruguay, 5D+ Draco I Latam Income Plus Segregated
Portfolio, a company incorporated under the laws of the Cayman Islands, and Biotech Investment Holding Ltd., a company incorporated under
the laws of the British Virgin Islands (the “Reporting Persons”). The principal business address of DRACO Capital
Investment Management Company S.A. is Dr. Luis Bonavita 1294, Office 2410, Montevideo, Uruguay. The principal business address of
5D+ Draco I Latam Income Plus Segregated Portfolio is c/o Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman KY1-9009,
Cayman Islands. The principal business address of Biotech Investment Holding Ltd. is 3076 Sir Francis Drake’s Highway, P.O.
Box 3463, Road Town, Tortola, British Virgin Islands.
(d) There were no criminal proceedings during
the last five years referred to in Item 2(d), in which the Reporting Persons or their executive officers were convicted (excluding traffic
violations or similar misdemeanors).
(e) None of the Reporting Persons has,
during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a
result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating
activities subject to, Federal or state securities laws or finding any violation with respect to such laws.
|
Item 3.
|
Source and Amount of Funds or Other Consideration.
|
|
|
|
The funds for the purchase of the Shares beneficially
owned by the Reporting Persons came from the working capital of 5D+ Draco I Latam Income Plus Segregated Portfolio and Biotech Investment
Holding Ltd.
No borrowed funds were used to purchase the Shares, other than any borrowed
funds used for working capital purposes in the ordinary course of business.
|
Item 4.
|
Purpose of Transaction.
|
The Reporting Persons have
acquired their Shares of the Issuer for investment. The Reporting Persons evaluate their investment in the Shares on a continual basis.
The Reporting Persons have no plans or proposals as of the date of this filing which, other than as expressly set forth below, would relate
to or would result in: (a) any extraordinary corporate transaction involving the Issuer; (b) any change in the present Board of Directors
or management of the Issuer; (c) any material change in the present capitalization or dividend policy of the Issuer; (d) any material
change in the operating policies or corporate structure of the Issuer; (e) any change in the Issuer's charter or by-laws; (f) the Shares
of the Issuer ceasing to be delisted from a national securities exchange or ceasing to be authorized to be quoted in an inter-dealer quotation
system of a registered national securities association; or (g) causing the Issuer becoming eligible for termination of registration pursuant
to Section 12(g)(4) of the Securities Exchange Act of 1934.
The Reporting Persons,
however, reserve the right, at a later date, to effect one or more of such changes and may acquire additional shares and dispose of or
enter into other transactions in the Shares they may be deemed to beneficially own.
The Reporting Persons reserve
the right to be in contact with members of the Issuer's management, the Issuer's Board of Directors, other significant shareholders and
others regarding alternatives that the Issuer could employ to maximize shareholder value.
The Reporting Persons further
reserve the right to act in concert with any other shareholders of the Issuer, or other persons, for a common purpose should it determine
to do so, and/or to recommend courses of action to management and the shareholders of the Issuer.
Item 5.
|
Interest in Securities of the Issuer.
|
(a-e) As of the date
hereof, DRACO Capital Investment Management Company S.A. may be deemed to be the beneficial owner of 7,991,226 Shares (19.4%) of
the Issuer, based upon the 41,087,803 Shares outstanding as of May 28, 2021, according to the Issuer’s Form S-8 POS filed on
June 1, 2021. DRACO Capital Investment Management Company S.A. has the sole power to vote or direct the vote of 0 Shares, DRACO
Capital Investment Management Company S.A. has the shared power to vote or direct the vote of 7,991,226 Shares, DRACO Capital Investment
Management Company S.A.. has the sole power to dispose or direct the disposition of 0 Shares and DRACO Capital Investment Management Company
S.A. has the shared power to dispose or direct the disposition of 7,991,226 Shares to which this filing relates.
As of the date hereof, 5D+ Draco
I Latam Income Plus Segregated Portfolio may be deemed to be the beneficial owner of 7,991,226 Shares (19.4%) of the Issuer, based upon
the 41,087,803 Shares outstanding as of May 28, 2021, according to the Issuer’s Form S-8 POS filed on June 1, 2021. 5D+ Draco
I Latam Income Plus Segregated Portfolio has the sole power to vote or direct the vote of 0 Shares, the 5D+ Draco I Latam Income Plus
Segregated Portfolio has the shared power to vote or direct the vote of 7,991,226 Shares, 5D+ Draco I Latam Income Plus Segregated Portfolio
has the sole power to dispose or direct the disposition of 0 Shares and the 5D+ Draco I Latam Income Plus Segregated Portfolio has the
shared power to dispose or direct the disposition of 7,991,226 Shares to which this filing relates.
As of the date hereof,
Biotech Investment Holding Ltd. may be deemed to be the beneficial owner of 7,991,226 Shares (19.4%) of the Issuer, based upon the 41,087,803
Shares outstanding as of May 28, 2021, according to the Issuer’s Form S-8 POS filed on June 1, 2021. Biotech Investment
Holding Ltd. has the sole power to vote or direct the vote of 0 Shares, Biotech Investment Holding Ltd. has the shared power to vote
or direct the vote of 7,991,226 Shares, Biotech Investment Holding Ltd. has the sole power to dispose or direct the disposition of 0
Shares and Biotech Investment Holding Ltd. has the shared power to dispose or direct the disposition of 7,991,226 Shares to which this
filing relates.
The Reporting Persons may
be deemed to constitute a group for purposes of Rule 13d-3 under the Exchange Act.
Except for the transaction
reported in Item 6 below, the trading dates, number of Shares purchased or sold and the price per share for all transactions in the Shares
since the last Schedule 13D filed by the Reporting Persons are set forth in Exhibit B and were effected in the open market. The Reporting
Persons specifically disclaim beneficial ownership in the Shares reported herein except to the extent of their pecuniary interest therein.
Item 6.
|
Contracts, Arrangements, Understandings or Relationships with Respect
|
|
to Securities of the Issuer.
|
On July 30, 2021, Biotech
Investment Holding Ltd. made a payment-in-kind to the creditor, an affiliate of the issuer, of 1,006,897 Shares, with applicable interest
paid in cash, in satisfaction of the outstanding price due in connection with the pledge transaction previously reported herein. Following
such payment, the applicable pledge agreement was terminated. Other than as set forth in this Schedule 13D, the Reporting Persons do
not have any contract arrangement, understanding or relationship with any person with respect to securities of the Issuer.
Item 7.
|
Material to be Filed as Exhibits.
|
Exhibit A
|
Joint Filing Statement
|
Exhibit B
|
Except for the transaction reported in Item 6 above, a description of the transactions in the Shares that were effected by the Reporting Persons since the last Schedule 13D is filed herewith as Exhibit B.
|
SIGNATURE
After reasonable inquiry and to the best of
my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
August 5, 2021
|
|
(Date)
|
|
|
|
|
|
DRACO Capital Investment Management Company S.A.
|
|
|
|
By: /s/ German Firpo
|
|
German Firpo
|
|
President
|
|
5D+ Draco I Latam Income Plus Segregated Portfolio
|
|
|
|
By: /s/ Ignacio Fravega
|
|
Ignacio Fravega
|
|
Director
|
|
Biotech Investment Holding Ltd.
|
|
|
|
By: /s/ Roberto Schlotthauer
|
|
Roberto Schlotthauer
Director
|
|
|
|
By: /s/ Ignacio Azumendi
|
|
Ignacio Azumendi
Director
|
* The Reporting Persons disclaim beneficial ownership in the Shares reported
herein except to the extent of their pecuniary interest therein.
Attention: Intentional misstatements or omissions of fact
constitute Federal criminal violations (see 18 U.S.C. 1001).
Exhibit A
AGREEMENT
The undersigned agree that this Schedule 13D dated
August 5, 2021 relating to the Ordinary Shares, par value US$0.0001 per share of Bioceres Crop Solutions Corp. shall be filed on behalf
of the undersigned.
DRACO Capital Investment Management Company S.A.
|
|
|
|
By: /s/ German Firpo
|
|
German Firpo
|
|
President
|
|
5D+ Draco I Latam Income Plus Segregated Portfolio
|
|
|
|
By: /s/ Ignacio Fravega
|
|
Ignacio Fravega
|
|
Director
|
|
Biotech Investment Holding Ltd.
|
|
|
|
By: /s/ Roberto Schlotthauer
|
|
Roberto Schlotthauer
|
|
Director
|
|
By: /s/ Ignacio Azumendi
|
|
Ignacio Azumendi
|
|
Director
|
|
Exhibit B
TRANSACTIONS IN SHARES BY ACCOUNTS ADVISED
BY THE REPORTING PERSONS
Transaction
|
Date
|
Shares
|
Price
|
Purchase
|
07/28/2021
|
4,669
|
$13.7235
|
Purchase
|
07/28/2021
|
2,200
|
$13.7655
|
Purchase
|
07/29/2021
|
1,700
|
$13.9893
|
Purchase
|
07/29/2021
|
100
|
$13.84
|
Purchase
|
07/29/2021
|
600
|
$13.9583
|
Purchase
|
07/29/2021
|
1,000
|
$13.9878
|
Purchase
|
07/29/2021
|
200
|
$14.1
|
Purchase
|
07/29/2021
|
1,332
|
$14.1038
|
Purchase
|
07/29/2021
|
1,087
|
$13.9192
|
Purchase
|
07/29/2021
|
500
|
$13.8383
|
Purchase
|
07/29/2021
|
1,100
|
$13.9227
|
Purchase
|
07/29/2021
|
500
|
$13.921
|
Purchase
|
07/29/2021
|
300
|
$13.7167
|
Purchase
|
07/30/2021
|
5,400
|
$14.0245
|
Purchase
|
07/30/2021
|
2,000
|
$14.19
|
Purchase
|
07/30/2021
|
7,200
|
$14.0877
|
Purchase
|
07/30/2021
|
1,600
|
$14.0481
|
Purchase
|
07/30/2021
|
8,000
|
$14.0536
|
Purchase
|
07/30/2021
|
100
|
$14.35
|
Purchase
|
07/30/2021
|
3,000
|
$13.9941
|
Purchase
|
07/30/2021
|
8,700
|
$14.1053
|
Purchase
|
07/30/2021
|
200
|
$14.325
|
Purchase
|
07/30/2021
|
100
|
$14
|
Purchase
|
07/30/2021
|
5,900
|
$14.0848
|